Cystic interstitial lung disease - a rare disease?

Philipp Markart (Giessen, Germany)

Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Session: CC4 Diagnosis of cystic interstitial lung disease
Session type: Challenging clinical cases
Number: 1689

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Philipp Markart (Giessen, Germany). Cystic interstitial lung disease - a rare disease?. International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015

Pathophysiology of cystic fibrosis lung disease
Source: Eur Respir Monogr 2014; 64: 1-13
Year: 2014


Cystic lung disease associated with Sjögren's syndrome: 3 cases
Source: Annual Congress 2009 - Various backgrounds in diffuse parenchymal lung disease
Year: 2009

Monitoring early lung disease in cystic fibrosis: where are we now?
Source: Breathe 2014; 10: 34-47
Year: 2014



How to diagnose cystic interstitial lung disease
Source: International Congress 2015 – CC4 Diagnosis of cystic interstitial lung disease
Year: 2015



A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


MRI detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Progressive fibrosis is common in patients with Sjögren’s syndrome and Interstitial lung disease
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021


Using the ILD-GAP model to predict mortality in chronic interstitial lung disease
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Study of factors affecting mortality in ILD cases over 2 years
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005

What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Idiopathic pulmonary fibrosis: a treatable disease?
Source: Eur Respir J 2003 Dec 01;22(6):872-873
Year: 2003


Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease
Source: Eur Respir Rev, 27 (150) 180110; 10.1183/16000617.0110-2018
Year: 2018